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Abstract 32 
Background: Epidemiological data show that traffic-related air pollution contributes to the 33 
increasing prevalence and severity of asthma. DNA methylation (DNAm) changes may 34 
elucidate adverse health effects of environmental exposures.  35 
 36 
Objectives: To assess the effects of allergen and diesel exhaust (DE) exposures on global 37 
DNAm and its regulation enzymes in human airway epithelium. 38 
 39 
Methods: 11 participants, including 7 with and 4 without airway hyperresponsiveness (AHR), 40 
were recruited for a randomized, double-blinded crossover study. Each participant had 3 41 
exposures: filtered air + saline (FA-S), filtered air + allergen (FA-A), and DE + allergen (DE-42 
A). 48 hours post-exposure, endobronchial biopsies and bronchoalveolar lavages (BAL) were 43 
collected. Levels of DNA methyltransferases (DNMTs) and ten-eleven translocation enzymes 44 
(TETs), 5-methylcytosine (5mC), and 5-hydroxymethylcytosine (5hmC) were determined by 45 
immunohistochemistry. Cytokines and chemokines in BAL were measured by 46 
electrochemiluminescence multiplex assays. 47 
 48 
Results: Predominant DNMT (pDNMT, the most abundant among DNMT1, DNMT3A, and 49 
DNMT3B), and predominant TET (pTET, the most abundant among TET1, TET2, and TET3) 50 
were participant-dependent. 5mC and its regulation enzymes differed between participants with 51 
and without AHR at baseline (FA-S) and in response to allergen challenge (regardless of DE 52 
exposure). pDNMT and pTET correlated with lung function. Allergen challenge effect on 53 
interleukin-8 in BAL was modified by TET2 baseline levels in the epithelium.  54 
 55 
Conclusions: Response to allergen challenge is associated with key DNAm regulation 56 
enzymes. This relationship is generally unaltered by DE co-exposure but is rather dependent 57 
on AHR status. These enzymes therefore warranted further inquiry regarding their potential in 58 
diagnosis, prognosis, and treatment of asthma. 59 
 60 
Clinical implications: 61 
In those with hyperresponsive airways, lung function changes induced by allergen inhalation 62 
may be due to changes in enzymes that regulate DNA methylation. 63 
 64 
Capsule Summary 65 
This randomized, double-blinded, controlled human exposure, crossover study reveals that 66 
response to allergen challenge is associated with key DNA methylation regulation enzymes, 67 
especially in participants with hyperresponsive airways. 68 
 69 
Keywords: Crossover human study, ten-eleven translocation (TET), DNA methylation 70 
(DNAm), asthma, allergen, diesel exhaust (DE) 71 
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Abbreviations: 73 
5hmC:  5-Hydroxymethylcytosine 
5mC:  5-Methylcytosine 
AHR:  Airway Hyperresponsiveness 
AR:  Allergic Rhinitis 
BAL:  Bronchoalveolar Lavages 
DE:  Diesel Exhaust 
DEP:  Diesel Exhaust Particle 
DNAm:  DNA Methylation 
DNMT:  DNA Methyltransferase  
FA:  Filtered Air 
FEF 25-75%:  Forced Expiratory Flow at 25–75% of FVC 
FEV1:  Forced Expiratory Volume in 1 Second 
FVC:  Forced Vital Capacity 
GM-CSF:  Granulocyte-macrophage Colony-Stimulating Factor 
HBECs:  Human Bronchial Epithelial Cells  
HDM:  House Dust Mite 
Iavg Average Intensity of all Pixels 
IHC:  Immunohistochemistry  
IL:  Interleukin 
IP-10:  IFN-γ-induced Protein 10  
LLOD:  Lower Limit of Detection 
LME:  Liner Mixed Effects 
MCP-1:  Monocyte Chemoattractant Protein-1 
PBMCs:  Peripheral Blood Mononuclear Cells 
pDNMT:  Predominant DNMT 
PM2.5:  Particulate Matter with a Diameter of 2.5 Micromole or Less 
pTET:  Predominant TET 
RT Room Temperature 
TARC:  Thymus and Activation Regulated Chemokine  
TET:  Ten-Eleven Translocation 
TRAP:  Traffic-related Air Pollution 
74 
Introduction 75 
Traffic-related air pollution (TRAP) contributes to increased morbidity and mortality of 76 
respiratory diseases, especially asthma (1). Epidemiological studies show that chronic exposure 77 
to TRAP, of which diesel exhaust (DE) is a major component, is related to an increased 78 
incidence of asthma, and short-term spikes in TRAP can induce airway hyperresponsiveness 79 
(AHR) in asthmatic patients (2, 3). We have previously demonstrated using controlled human 80 
exposure studies that short-term DE exposure alters DNA methylation (DNAm) in the human 81 
lung epithelium and peripheral blood mononuclear cells (PBMCs) (4, 5).  82 
    DNA methylation (5mC) is the addition of methyl groups to primarily DNA cytosines(6). 83 
DNA methyltransferases (DNMTs) are the enzymes responsible for 5mC deposition and 84 
include DNMT3A and DNMT3B which perform de-novo 5mC and DNMT1 which is involved 85 
in the maintenance of 5mC following DNA replications (7, 8). DNA demethylation can occur 86 
through passive or active mechanisms. Passive DNA demethylation occurs in the absence of 87 
maintenance methylation during DNA replication (9). Active DNA demethylation is mediated 88 
by the ten-eleven translocation (TET) methylcytosine dioxygenases (10) which include TET1, 89 
TET2, and TET3. TET enzymes catalyze the oxidation of 5-methylcytosine to 5-90 
hydroxymethylcytosine (5hmC), 5-formylcytosine, and 5-carboxylcytosine (11, 12). Of these, 91 
5hmC is the most abundant, playing poorly understood roles in genome function (13). Dynamic 92 
regulation of DNA methylation and demethylation modulates a wide range of processes, 93 
including cell differentiation, cellular ageing and oncogenic transformation (14-17).  94 
    Recently, the role of TET enzymes in asthma has gained significant interest. Somineni et 95 
al. showed decreased methylation of cg23602092 in the TET1 promoter and increased global 96 
5hmC in nasal mucosa samples of asthmatic individuals compared to healthy participants (18). 97 
This study reported 5mC at cg23602092 positively correlated with TRAP concentrations by 98 
utilizing a land-use regression model as a proxy estimate of DE particles (DEP), and showed 99 
that in vitro DEP exposures induced cg23602092 methylation in human bronchial epithelial 100 
cells (HBECs) at 24 hours (h). Additionally, in TET1-knockout mice, loss of the TET1 enzyme 101 
aggravated allergen-induced airway inflammation (19). The evidence above supports the 102 
notion of TET enzymes contributing to the effects of environmental exposures (e.g. allergen 103 
and TRAP) on asthma pathophysiology (20), but the overall outcomes are currently unclear. 104 
Given the data from epidemiological and animal studies, evaluating the role of TET family 105 
enzymes, including the understudied TET2 and TET3, in human airways is warranted, and may 106 
elucidate additional pathways linking environmental exposures to asthma.   107 
    In this study, we performed a controlled human exposure crossover study to investigate 108 
changes in DNA methylation, DNA hydroxymethylation and their regulation enzyme 109 
expression, including DNMTs and TETs, in response to acute allergen challenge and DE 110 
exposures in vivo in the human bronchial epithelium. We also analyzed the correlation between 111 
these biomarkers and the allergic airway inflammation, which was evaluated by the cytokines 112 
and chemokines in the bronchoalveolar lavages (BAL) and the lung function.  113 
Methods 114 
Study design and participants  115 
11 allergen-sensitized participants, including 7 with AHR and 4 without AHR, were recruited. 116 
These participants were recruited based on sensitization to common allergens, and were 117 
secondarily grouped by AHR status as an objective way to stratify based on objective 118 
physiological measures. While participants’ responding differently by AHR status was not the 119 
primary concern in the initial design of this study, it allowed for some important questions to 120 
be asked in the current analysis in spite of modest sample size. AHR was evaluated by 121 
measurement of forced expiratory volume in 1 second (FEV1) during methacholine challenge, 122 
using the 2-minute tidal breathing technique, and participant-specific allergen (either house 123 
dust mite (HDM), pacific grass or birch pollen) concentration determined with skin prick 124 
testing during screening visits (21). The provocative concentration of methacholine eliciting a 125 
20% drop in FEV1 (PC20) during screening classified participants as either being AHR (PC20 ≤ 126 
8 mg/mL) or not AHR (PC20 > 8 mg/mL). During screening, each participant underwent an 127 
allergen inhalation challenge to determine a dose of allergen that induce 20% decrease in FEV1. 128 
We used the consistent dose and allergen throughout the study for each participant. This 129 
randomized, double-blinded, controlled human exposure crossover study took place between 130 
April 2013 and April 2017 (Clinical Trials ID: NCT02017431). Specimens and clinical data 131 
were collected with informed consent using protocols approved by the University of British 132 
Columbia Clinical Research Ethics Board (H11-01831) in Vancouver, BC, Canada. The study 133 
design and exposure procedures have been described previously (22). Briefly, each participant 134 
underwent 3 distinct exposures, in a random order, with at least a 4-week washout period 135 
between exposures: filtered air (FA) + 0.9% saline (FA-S), FA + participant-specific allergen 136 
(FA-A), and DE (diluted to 300 μg/m3 of particulate matter sized 2.5 microns in diameter or 137 
less (PM2.5)) + allergen (DE-A). FA and DE exposures were 2 h in duration. 1 h post-exposure, 138 
a 2-minute inhaled allergen challenge was conducted (22, 23). An allergen PC20 dose, which 139 
was determined at screening based on PC20 and skin prick wheal size for each participant (24), 140 
was applied for allergen challenge. The characteristics of 11 participants are listed in Table 1. 141 
 142 
Lung function 143 
Spirometry measurements were performed based on the American Thoracic Society’s 144 
guidelines (25), and related results were previously reported (22).  145 
 146 
Bronchoscopy procedures and processing of endobronchial biopsy 147 
The bronchoscopy procedure (26) and endobronchial biopsy processing techniques (27, 28) 148 
were adapted from work described previously. In brief, a bronchoscopy was performed post-149 
exposure (48h after the start of each exposure), for each condition. The biopsies collected were 150 
fixed in ice-cold acetone with protease inhibitors iodoacetamide (20 mM, Sigma, Oakville, ON) 151 
and phenylmethylsulfonylfluoride (2 mM, Sigma, Oakville, ON) at 4 °C overnight (16–24h). 152 
On the second day, the protease inhibitors were washed out of biopsies by replacing the acetone 153 
solution with fresh acetone at room temperature (RT) and then with 100% methyl 154 
benzoate (Sigma, Oakville, ON). Biopsies were infiltrated with glycol methacrylate acrylic 155 
(GMA) solution A containing 5% methyl benzoate (replaced 3 times for 2h each at 4 °C). 156 
Biopsies were embedded in polymerized glycol methacrylate acrylic (GMA) (29). The JB-4 157 
Embedding Kit (Polysciences, Warrington, PA) was used following manufacturer’s 158 
instructions. The blocks were stored with desiccant at -20°C until sectioned. 2 μm thick sections 159 
from biopsies were cut using an ultra-microtome (Leica EM UC6) and placed on poly-l-lysin-160 
coated slides for immunohistochemistry (IHC) staining. 161 
 162 
IHC staining and quantification  163 
IHC was performed to evaluate the levels of DNMT1, DNMT3A, DNMT3B, TET1, TET2, 164 
TET3, 5mC, and 5hmC,based on previous work (27, 28), with modifications optimized 165 
antibody concentration and antigen retrieval steps. Heat-induced epitope retrieval was applied. 166 
Sodium citrate buffer was used for TETs staining, and Tris-EDTA buffer was applied for 167 
DNMTs, 5mC, and 5hmC staining. After antigen retrieval, the slides were washed twice with 168 
ddH2O. The sections were permeabilized twice with 0.4% Triton-100 in Phosphate Buffered 169 
Saline with 0.1% Tween 20 (PBST) for 10 min and washed with Tris-buffered saline (TBS, 5 170 
mins × 3). 0.3% H2O2 in 0.1% aqueous sodium azide was applied to inhibit endogenous 171 
peroxidase activity following washes with TBS (5 mins × 3). 20% fetal calf serum and 1% 172 
bovine serum albumin in Dulbecco’s modified Eagle’s minimal essential medium (DMEM) 173 
was applied at RT for 30 mins to block the sections from non-specific antibody binding. 174 
Primary antibodies (see Table S1) were incubated with each specimen at 4°C overnight. On the 175 
next day, the sections were washed with TBS (5 mins × 3) and incubated with biotinylated 176 
secondary antibodies at RT for 1h. After washes with TBS (5 mins × 3), the sections were 177 
incubated with VECTASTAIN® Elite ABC (avidin-biotin complex) HRP Kit (Vector, PK6100) 178 
at RT for 2h and washed with TBS (5 mins × 3). AEC (3-amino-9-ethylcarbazole) peroxidase 179 
substrate kit (Vector, SK-4200) was used for color development with 20 mins incubation. The 180 
sections were counterstained with Mayer’s Hematoxylin (Sigma-Aldrich, MHS16) and 181 
covered with CC/mount (Sigma-Aldrich, C9368) and Permount (Fisher Scientific, SP15100) 182 
successively for long-term storage.  183 
    The slides were scanned with Aperio digital pathology slide scanners (ScanScope AT2) 184 
(Leica Biosystem, Buffalo Grove, IL, USA) and quantified with Aperio Positive Pixel Count 185 
Algorithm (v9) using Aperio ImageScope software (v12.4.0.5043). The epithelium was gated 186 
along the basement membrane (Figure S1). Only the epithelial layer was included in the 187 
analysis of this study. The average intensity of all pixels (Iavg) was utilized to quantify the 188 
level of the target protein. Higher values of Iavg indicate lower levels of the target.  189 
 190 
Electrochemiluminescent multi-plex assay 191 
The cytokines and chemokines secreted into the BAL were measured using the V-PLEX 192 
Human Cytokine 30-Plex Kit (Meso Scale Diagnostics, Rockville, Maryland, USA). The list 193 
of the cytokines and chemokines is shown in the supplementary materials. The assay was 194 
performed following the manufacturer’s instructions with 2-fold (cytokine panel 1 and 195 
proinflammatory panel 1) and 4-fold (chemokine panel 1) dilution of BAL in assay diluent. 196 
The lower limit of detection (LLOD) was set at the signal intensity that was 2.5 standard 197 
deviations above the background noise in the blank. For statistical analysis, values below the 198 
LLOD were replaced with ½ of the respective LLOD value. Eotaxin, IFN-γ, IL-4, IL-8(HA), 199 
IL-10, IL-12p70, IL-13, MCP-4, MDC, MIP-1α, and TNF-β were not reliably detectable above 200 
the LLOD and were excluded from statistical analysis.  201 
 202 
Statistical analysis 203 
Exposure effects were assessed using linear mixed-effects (LME) models (nlme package 204 
version 3.1-142) in R (version 3.6.1). Conditions (FA-S, FA-A, and DE-A) were used as fixed 205 
effects and participant identification as a random effect. This model was conducted in 11 206 
participants (Figure 2-4), no AHR group (Figure 5), and AHR group (Figure 5), respectively. 207 
A second model was employed to test the baseline level (FA-S) of the biomarkers of interest, 208 
between the no AHR group and AHR group. Therefore, AHR status was used as a fixed effect 209 
and participant identification as a random effect (Figure 5). A third model was applied to test 210 
potential role of DNAm biomarkers levels (5mC, 5hmC, 5mC/5hmC ratio, DNMTs, TETs, 211 
pDNMT, and pTET) at baseline in modulating the exposure responses, and condition-by-212 
DNAm biomarker baseline level (e.g. low TET2 vs. high TET2) interaction was the fixed effect 213 
in this model (Figure 7G). Spearman’s correlation was applied to test the correlation between 214 
DNA methylation biomarkers, including 5mC, 5hmC, DNMTs, TETs, pDNMT, and pTET, and 215 
clinical lung function (Figure 6) or cytokine and chemokine secretion in the BAL (Figure 7A-216 
E). Spearman’s correlation coefficient R and p-value were computed. A p < 0.05 was 217 
considered to indicate a statistically significant difference. The details of missing data are 218 
shown in Table S2.  219 
Results 220 
The predominant DNMT and TET enzymes in human bronchial epithelium were 221 
participant-dependent 222 
Figure 1A-1B show the IHC staining levels of DNMT family (DNMT1, DNMT3A, and 223 
DNMT3B) and TET family (TET1, TET2, and TET3) in the bronchial biopsies from the same 224 
participant (Participant ID: 5, condition: FA-S). It’s worth noting that, the levels of DNMT 225 
family and TET family in human bronchial epithelium under FA-S condition varied from 226 
person to person. To better understand the role of the most abundant enzyme, we defined, for 227 
each study participant, the most abundant DNMT among DNMT1, DNMT3A, and DNMT3B 228 
in the airway epithelium under FA-S condition as the predominant DNMT (pDNMT), and the 229 
most abundant TET among TET1, TET2, and TET3 as the predominant TET (pTET). For the 230 
example in Figure 1A-1B, the pDNMT was DNMT3B and the pTET was TET3 in this 231 
participant. At baseline (FA-S), 6 out of 11 participants were DNMT3B predominant and 8 out 232 
of 11 participants were TET3 predominant (See Figure 1 and Table 1). Similar results were 233 
found in an in vitro analysis of human primary bronchial epithelial cells from another 234 
independent study (Table S3). Among those 8 participants, 4 were DNMT3B predominant and 235 
6 were TET3 predominant.  236 
 237 
pDNMT and pTET decreased following allergen challenge, irrespective of DE exposure  238 
To investigate the effects of allergen mono-exposure (FA-A) and DE + allergen co-exposure 239 
(DE-A) on the DNMT and TET family expression, IHC was applied with the bronchial biopsies 240 
which were collected at 48h post-exposure. Representative staining levels of DNMT1, 241 
DNMT3A, and DNMT3B levels are shown in Figure 2A. Examining the levels of DNMT1, 242 
DNMT3A and DNMT3B individually following FA-A or DE-A exposure (Figure 2B-2D) 243 
revealed no significant changes in DNMT1, DNMT3A or DNMT3B, respectively. However, a 244 
focus on the pDNMT level showed a significant decrease following FA-A and DE-A exposures 245 
(FA-A vs. FA-S, p = 0.02; DE-A vs. FA-S, p = 0.006, Figure 2E). The levels of TET family 246 
members were also evaluated following three exposures in the 11 participants (Figure 3A-3D). 247 
Following allergen mono-exposure, TET1 and TET3 were not significantly changed while 248 
TET2 was decreased (p = 0.02, Figure 3C). With co-exposure to DE and allergen, both TET2 249 
and TET3 were decreased (both p = 0.02, Figure 3C-D). Corresponding to the changes of 250 
pDNMT, pTET was also decreased following both FA-A and DE-A exposures (FA-A vs. FA-251 
S, p = 0.04; DE-A vs. FA-S, p = 0.009, Figure 3E).  252 
 253 
The ratio of 5mC to 5hmC decreased following allergen challenge, irrespective of DE 254 
exposure 255 
Global DNA methylation and hydroxymethylation in the human bronchial epithelium were 256 
measured by IHC (Figure 4A). 5mC showed non-significant decreasing trend following both 257 
FA-A and DE-A exposures, relative to FA-S (p = 0.06 and p = 0.16, respectively, Figure 4B). 258 
5hmC is an emerging epigenetic modification that plays poorly understood roles in genome 259 
function. It is also an intermediate in the DNA demethylation pathway allowing us to examine 260 
the ratio of 5mC to 5hmC as a rough measure of the balance between DNA methylation and 261 
DNA demethylation (30). The ratio of 5mC to 5hmC was decreased following both FA-A and 262 
DE-A exposures (p = 0.006 and p = 0.03, Figure 4D).  263 
 264 
5mC levels and associated enzymes differed between participants with and without AHR 265 
under baseline conditions and in response to allergen challenge 266 
We explored whether the levels of these DNAm biomarkers (5mC, 5hmC, 5mC/5hmC ratio, 267 
DNMTs, TETs, pDNMT, and pTET) in the bronchial epithelium are different at the baseline 268 
between AHR group and non-AHR group. The baseline (FA-S) levels of TET1, 5mC, and the 269 
5mC/5hmC ratio in the bronchial epithelium were higher in participants with AHR than those 270 
without AHR (p = 0.03, p = 0.04, and p = 0.04, respectively, Figure 5E, 5I, 5K). We further 271 
investigated whether these DNAm biomarkers between AHR group and non-AHR group had 272 
different responses following exposures by using LME models. pDNMT, pTET, 5mC, and the 273 
5mC/5hmC ratio in the bronchial epithelium decreased following both FA-A and DE-A in 274 
participants with AHR, but not in non-AHR (Figure 5D, 5H, 5I, 5K). P-values are listed in 275 
Table S4. Therefore, global DNA methylation and its regulation enzymes are more susceptible 276 
to allergen challenge in the context of AHR. 277 
 278 
DNMT and TET were correlated with lung function 279 
To investigate the association between DNAm biomarkers and lung function, including FEV1, 280 
FVC, FEV1/FVC, and FEF 25-75%, at 48h post-exposure, Spearman’s correlation was 281 
computed (Selected results are shown in Figure 6, and more related results are shown in Figure 282 
S2. The correlation analyses grouped by condition and AHR status are shown in Figure S3 and 283 
Figure S4). FEV1/FVC was positively correlated with DNMT1 (R = 0.4, p = 0.027, Figure 6A), 284 
DNMT3B (R = 0.4, p = 0.028, Figure 6C), and pDNMT (R = 0.43, p = 0.018, Figure 6D) 285 
levels, respectively, in the bronchial epithelium. FEV1 was positively correlated with the levels 286 
of TET2 (R = 0.46, p = 0.0099, Figure 6F) and pTET (R = 0.42, p = 0.019, Figure 6H), 287 
respectively, in the bronchial epithelium. These data suggest that DNMT and TET family 288 
involve with the regulation of lung function. 289 
 290 
TET levels were correlated with cytokines and chemokines in the BAL 291 
To understand the association between DNAm biomarkers and lung inflammation, we 292 
correlated DNAm biomarkers with cytokine and chemokine levels in BAL by Spearman’s 293 
correlation (including 3 conditions). Figure 7A-E only show those plots when the Spearman’s 294 
correlation coefficient R is above 0.4 and the p-value is below 0.05. TET1 levels negatively 295 
correlated with monocyte chemoattractant protein-1 (MCP1), a chemokine that functions in the 296 
recruitment of monocytes, memory T-helper cells and dendritic cells (31, 32), in the BAL (R = 297 
-0.43, p = 0.016, Figure 7A), and TET2 levels negatively correlated with granulocyte-298 
macrophage colony-stimulating factor (GM-CSF, R = -0.5, p = 0.0037, Figure 7B), a cytokine 299 
known to stimulate the differentiation of macrophages and eosinophils (33, 34), and thymus 300 
and activation regulated chemokine (TARC, R = -0.44, p = 0.011, Figure 7C), which is also 301 
called CCL17 and is known as a chemotactic factor for T cells (35). pTET levels in the 302 
bronchial epithelium were negatively correlated with the secretion of Eotaxin-3 (R = -0.52, p 303 
= 0.0025, Figure 7D), a chemoattractant of eosinophils and basophils (36), and IL-5 (R = -0.5, 304 
p = 0.0033, Figure 7E), a colony-stimulating factor for eosinophils that induces the 305 
differentiation of B cells to immunoglobulin secreting cells (37, 38). The correlation analyses 306 
grouped by condition and AHR status are shown in Figure S5 and Figure S6. These results 307 
suggest that TET levels involve with the development of allergic airway inflammation. 308 
    To investigate whether these DNAm biomarkers’ baseline levels can be applied in the 309 
prognosis of the allergen and DE exposure responses, we did the subgroup analysis based on 310 
the baseline (FA-S) levels of these biomarkers one by one. For example, based on the median 311 
of TET2 level at baseline, the 11 participants were split into two groups, a low TET2 group (n 312 
= 6) and a high TET2 group (n = 5). Focusing on these two groups (Figure 7E) we next asked 313 
if there were any differences in the baseline levels of cytokines and chemokines and different 314 
responses following exposures (FA-A and DE-A). Intriguingly, IL-8 levels at baseline were 315 
higher in the high TET2 group than in those in the low TET2 group (means ± SEM = 38.8 ± 316 
14.1 pg/mL vs. 9.1 ± 1.2 pg/mL, p = 0.01). The exposure effects of FA-A and DE-A on IL-8 317 
secretion in the BAL were modified by TET2 levels (p = 0.03 and p = 0.01, respectively, Figure 318 
7F). The same analysis was also accomplished in the rest DNAm biomarkers, and the 319 
interaction between allergen (with or without DE) and TET2 level on IL-8 secretion in the BAL 320 
is the most impressive. 321 
    Finally, since our in vivo study samples did not include a DE mono-exposure so we added 322 
an in vitro component to the study and found that SRM2975, standardized diesel exhaust 323 
particles, decreased the mRNA levels of TET1 and TET2 in the BEAS-2B cell line (Figure S7).   324 
Discussion  325 
This study documents, for the first time, changes in the levels of DNAm regulation 326 
enzymes, including pDNMT and pTET, in human airway epithelium following allergen mono-327 
exposure and DE + allergen co-exposure. These results provide solid evidence for the notion 328 
that environmental exposure can affect human airway through epigenetic regulation, even the 329 
acute allergen inhalation effect can last 48h. No significant difference was found in the 330 
comparison between DE-A and FA-A, which infers that the effect of allergen challenge on 331 
global DNAm biomarkers were not significantly affected by DE. Given the lack of a DE mono-332 
exposure in our intact human model, which is a recognized limitation, we used an in vitro 333 
correlate to show decreased the mRNA levels of TET1 and TET2 in the BEAS-2B cell line 334 
(Figure S7). Whether more effects will be found on DNA methylation of specific genes or not 335 
needs further investigation. Correspondingly, DEP exposures induced the methylation of 336 
cg23602092 in TET1 promoter in HBECs (19).  337 
    Our data shows higher TET1 levels in AHR participants’ bronchial epithelial cells, in 338 
comparison to normally responsive participants. Meanwhile, Somineni et al. showed that 339 
methylation of the TET1 promoter was lower in asthmatic children than non-asthmatic controls 340 
(27). These results suggest that higher TET1 levels in the asthmatic airway epithelium might 341 
be due to the hypomethylation of site(s) within the TET1 promoter. On the other hand, higher 342 
levels of TET1 seems paradoxical to global DNA hypermethylation in participants with AHR. 343 
Coincidentally, higher TET levels and global DNA hypermethylation was also found in the 344 
PBMCs of allergic rhinitis (AR) patients (39). TET-mediated 5hmC increases may also trigger 345 
passive replication-dependent DNA demethylation (40). The activity of DNMT1 can be 346 
dramatically suppressed (by a factor of >60) on a 5hmC-abundant DNA substrate (40). This 347 
suggests, therefore, that the increased TET level seen in atopic participants may not represent 348 
causation, but instead feedback regulation to counter the accumulation of aberrant DNA 349 
methylation. In interpreting these results, one should note that while we avoided experimental 350 
exposure to grass and tree allergen during their peak season, we cannot rule out some exposure 351 
to these allergens outside of the study setting. Any such exposure would bias results away from 352 
significant effects in our analysis, leading to potential type 2 error (falsely supporting null 353 
hypothesis). 354 
In our study, global DNA methylation and its regulation enzymes were more vulnerable 355 
to allergen challenge in participants with AHR, compared to those without AHR. These 356 
responses might be related to the higher TET1 and 5mC levels at baseline (FA-S condition) in 357 
the bronchial epithelium of AHR group than that of no AHR group. The results above suggest 358 
the underlying mechanism of AHR might be due to the differences in epigenetic stabilities 359 
between those with and without AHR. Several asthma-related genes, including forkhead box 360 
P3 (Fox P3), IFN-γ, IL-4, IL-13, and IL-17, have been found to be more susceptible to the 361 
modulation of DNA methylation in asthmatic participants (41-44). The evidence suggests that 362 
those with AHR may experience greater inflammatory responses following allergen challenge 363 
due to changes in the epigenome relative to those without AHR, and that those with AHR may 364 
have higher susceptibility to greater subsequent responses. Note however that not all our 365 
participants with AHR had clinical asthma, and those who were diagnosed with asthma were 366 
mild, so our results may not be generalizable to asthmatics of greater severity.  367 
The mechanism by which DNAm regulates the development of AHR is still not fully 368 
understood. The known mechanisms of DNAm include not only directly limiting the access to 369 
transcription factors and suppress the expression of the target genes (45), but also coordinating 370 
with histone variants, histone modifications, and non-coding RNAs in regulating gene 371 
expression (46, 47). The DNAm-regulated genes which are associated with asthma phenotypes 372 
are involved in the immune response, NO synthesis, lipid pathway, and pharmacologic receptor 373 
(48). DE and allergen in vitro exposure modified DNAm levels of genes in oxidative stress 374 
response, epithelial adherence junction signaling and immune cell responses, including Th1, 375 
Th2, macrophage and dendritic cell maturation pathway in HBECs (49). Our previous in vivo 376 
human study reveals that the order of exposure to DE and allergen determines the epigenetic 377 
signals (5). The effect of subsequent exposure to allergen and DE on DNAm of genes involved 378 
in cell adhesion and migration, protein localization/transport, angiogenesis, while DNAm of 379 
genes involved in protein metabolism and hormone/steroid stimulation are associated with 380 
subsequent exposure to DE and allergen (5). The potential role of DNA methylation in 381 
mediating the effect of allergen and DE exposures and the development of AHR still needs 382 
further investigation. 383 
    Zhang et al. demonstrated that the mRNA levels of TET1 in HBECs were increased at 1h 384 
following diesel exhaust particles (DEP) and house dust mite (HDM) exposures (in vitro), 385 
respectively, and returned to baseline levels at 4h (49). Earlier, the same team reported that 386 
TET1 mRNA was decreased at 4h by the same dose of DEP in HBECs (18). Our in vitro study 387 
found that SRM2975 decreased the mRNA levels of TET1 and TET2 in BEAS-2B at 2h, 6h, 388 
and 18h (Figure S7). While contrary to Zhang et al., perhaps due to the specific DEP used, its 389 
dose, the timing of sampling, or cell type examined, this is consistent with our in vivo finding 390 
that DE (in the context of allergen) did not increase TETs levels in human bronchial epithelium.  391 
    TET family members have been demonstrated to have a catalytic domain, comprising a 392 
Cys-rich and a double-stranded β helix domain, with all three TET members having 5mC 393 
oxidation properties (50). However, there are known differences among the TET members. 394 
Both TET1 and TET3 have CXXC domains, which have a high affinity for unmethylated CpG 395 
dinucleotides, whereas TET2 does not possess this domain(11). It has been widely reported 396 
that TET family enzymes are expressed and regulated in a dynamic and tissue-specific manner 397 
(11-13). TET1 and TET2 are highly expressed in mouse embryonic stem cells, while TET3 has 398 
a high abundance in oocytes and one-cell zygotes (51, 52). We found that TET1 is consistently 399 
predominant in human circulating dendritic cells among different participants (39). 400 
Unexpectedly, pTET was participant-dependent in human bronchial epithelium, as was 401 
pDNMT. This observation is important, especially when researchers are investigating the role 402 
of these enzymes in primary human samples or in in vivo human studies.  403 
    As lung epithelial cells serve as barriers to environmental exposures, DNA methylation 404 
of these cells has been demonstrated to be affected by various inhaled insults, including 405 
particulate matter, allergens, and tobacco smoke (5, 20, 53). We show global hypermethylation 406 
in AHR participants’ bronchial epithelium, compared to those without AHR, but demonstrate 407 
no significant difference between the global 5hmC levels in the epithelium of AHR and non-408 
AHR participants. In an independent study, global 5hmC levels in saliva were higher in 409 
asthmatics than non-asthmatics (n = 18 pairs) (18). Higher levels of global 5hmC was also 410 
found in the PBMCs from AR patients than those from healthy volunteers (39). This 411 
discrepancy might be due to the different sample types across these studies or the relatively 412 
small sample size of this study. Intriguingly, we observed that changes in 5mC and 5hmC 413 
following allergen challenge tended to be in the opposite directions. As a result, we showed 414 
that the 5mC/5hmC ratio significantly decreased following allergen challenge. Moreover, the 415 
ratio of 5mC to 5hmC declines with aging, caloric restriction (30), and mucosal hypertrophy 416 
in oral ulcers (54), but increases with prenatal mercury exposure (55) and colorectal cancer 417 
(56). The ratio of 5mC to 5hmC may be a sensitive marker to monitor environmental exposures 418 
and the development of inflammation and we recommend considering this when studying DNA 419 
methylation patterns following such exposures. 420 
There are important implications of our findings. Firstly, our data suggest that allergen 421 
exposure may have a great effect on triggering epigenetic regulation leading to the development 422 
of inflammation. However, it is important to consider the acute DE mono-exposure and DE + 423 
allergen co-exposure effects, to further investigate the complex interplay between different 424 
environmental exposures and asthma pathophysiology. Secondly, we show that TET levels in 425 
HBECs were correlated with not only allergen-induced FEV1 decline, but also with increased 426 
cytokines and chemokines in the BAL; this suggests that the TET family may play a role in 427 
instigating airway inflammation in the development of asthma. In support of this, TET2 SNP 428 
(rs10010325) was shown to correlate with lung function (57). To some extent, these findings 429 
indicate that compared to DNMT, TET changes may be a more sensitive biomarker for airway 430 
inflammation and, therefore, a more relevant focus for diagnosis and determining the prognosis 431 
of asthma. Interestingly, we demonstrated a correlation, between levels of these fundamental 432 
enzymes of DNA methylation and lung function, that suggests a potential physiologic 433 
relationship therein even after the primary effect of acute exposure (allergen leading to drop in 434 
FEV1) has resolved. However, further investigation is needed to uncover the mechanism by 435 
which TETs mediate the development of airway inflammation. Burleson et al. showed that IFN 436 
signaling and the aryl hydrocarbon receptor pathway are modulated by TET1 in an allergic 437 
airway inflammation mouse model (19). NF-κB activation leads to the repression of TET1 and 438 
higher immune infiltration in breast cancer, melanoma, lung cancer, and thyroid cancer (58). 439 
Increasing our knowledge of the upstream and downstream pathways of TET regulation could 440 
provide further mechanistic insight that may enhance asthma treatment or prevention.  441 
 442 
Conclusions 443 
Our data suggest that AHR participants whose bronchial epithelium is globally 444 
hypermethylated with higher TET enzyme expression may be more susceptible to 445 
environmental exposures. This controlled human exposure study provides new evidence of the 446 
acute effects of allergen challenge on epigenetic marks, which could be potentially used as 447 
biomarkers for the diagnosis, prognosis, and treatment of asthma. 448 
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  618 
Graphical abstract 619 
620 
AHR, airway hyperresponsiveness; FA-S, filtered air (FA) + saline; FA-A, FA + allergen; DE-621 
A, diesel exhaust (DE) + allergen; pDNMT, predominant DNA methyltransferase (the most 622 
abundant DNMT among DNMT1, DNMT3A, and DNMT3B); pTET, predominant ten-eleven 623 
translocation enzyme (the most abundant TET among TET1, TET2, and TET3); 5mC, 5-624 
methylcytosine; 5hmC, 5-hydroxymethylcytosine; FEV1, forced expiratory volume in 1 625 
second; FEV1% predicted, FEV1% of the participant divided by the average FEV1% in the 626 
population for any person of similar race, sex, age, and height; FVC, forced vital capacity.  627 
Figure and figure legends 628 
 629 
Figure 1. Predominant DNMT and TET enzymes in the human bronchial epithelium were 630 
participant-dependent. 631 
Representative images showing the immunohistochemistry (IHC) staining of DNA 632 
methyltransferases (DNMTs) (A), ten-eleven translocation enzymes (TETs) (B) and the 633 
negative control (NC) in human bronchial biopsies (Participant 5, condition: FA-S). DNMT3B 634 
was the predominant DNMT (pDNMT) and TET3 was the predominant TET (pTET) in the 635 
bronchial epithelium from this participant. Red staining shows specific target signals (DNMT 636 
or TET enzyme) from HRP/AEC/ABC detection kit, and blue staining shows hematoxylin 637 
counterstaining. Pie chart showing the number of individuals with predominant DNMT1, 638 
DNMT3A or DNMT3B (pDNMT) (C) and predominant TET1, TET2 or TET3 (pTET) (D) in 639 
human bronchial epithelial samples (taken from FA-S exposure) from 11 participants.  640 
 641 
Figure 2. pDNMT decreased following allergen challenge, irrespective of DE exposure. 642 
(A) Representative IHC staining images show DNMT1, DNMT3A, and DNMT3B levels in 643 
human bronchial epithelial samples (Participant ID: 3) at 48h after exposure to FA-S (negative 644 
control), FA + allergen (FA-A), or diesel exhaust (DE) (diluted to 300 μg/m3 of particulate 645 
matter sized 2.5 microns in diameter or less (PM2.5)) + allergen (DE-A), respectively. Means ± 646 
SEM of DNMT1, DNMT3A, DNMT3B, and pDNMT levels are shown in B, C, D, and E, 647 
respectively. The Aperio Positive Pixel Count Algorithm (v9) was applied in the quantification 648 
of the epithelial layer. Higher average intensity of all pixels (Iavg) indicates a lower level of 649 
the target. Linear mixed-effects (LME) model analysis was conducted. +: p < 0.1, *: p < 0.05, 650 
**: p < 0.01. 651 
 652 
Figure 3. pTET decreased following allergen challenge, irrespective of DE exposure. 653 
(A) Representative IHC staining images show TET1, TET2, and TET3 levels in the human 654 
bronchial epithelium (Participant ID: 6) at 48h following exposure to FA-S, FA-A, and DE-A, 655 
respectively. Means ± SEM of TET1, TET2, TET3, and pTET levels are shown in B, C, D, and 656 
E, respectively. LME model analysis was conducted. Data are presented as means ± SEM. *: p 657 
< 0.05, **: p < 0.01. 658 
 659 
Figure 4. The ratio of 5mC to 5hmC decreased following allergen challenge, irrespective 660 
of DE exposure. 661 
(A) Representative IHC staining images show global 5mC and 5hmC levels in the human 662 
bronchial epithelium (Participant ID: 3) at 48h following three exposures. Means ± SEM of 663 
global 5mC, 5hmC, and the ratio of 5mC to 5hmC are shown in B, C, and D, respectively. LME 664 
model analysis was conducted. Data are presented as means ± SEM. +: p < 0.1, *: p < 0.05, 665 
**: p < 0.01. 666 
 667 
Figure 5. Global 5mC levels and associated enzymes differed between participants with 668 
and without AHR under baseline conditions and in response to allergen challenge. 669 
The level of DNMTs (A-D) and TETs (E-H), global levels of 5mC (I) and 5hmC (J), and the 670 
5mC/5hmC ratio were grouped by participants’ airway hyperresponsiveness (AHR) status (7 671 
with AHR and 4 without AHR). The levels of TET1, 5mC, and the 5mC/5hmC ratio in the 672 
negative control (FA-S) were higher in the bronchial epithelium of AHR group than those of 673 
the non-AHR group (E, I, K). Global 5mC levels (I), 5mC/5hmC ratio (K) and their regulation 674 
enzymes, including pDNMT (D) and pTET (H), are more susceptible to allergen challenge 675 
(irrespective of DE exposure) in AHR group compared to non-AHR group. LME model 676 
analysis was conducted. Data are presented as means ± SEM. +: p < 0.1, *: p < 0.05, **: p < 677 
0.01, ***: p < 0.001. 678 
 679 
Figure 6. DNMT and TET were correlated with lung function. 680 
Spearman’s correlation was computed to analyze the association between DNAm biomarkers 681 
and lung function at 48h post-exposure. The correlation analyses between FEV1/FVC and 682 
DNMT1 (A), DNMT3A (B), DNMT3B (C), and pDNMT (D) are shown. The correlation 683 
analyses between delta FEV1 and TET1 (E), TET2 (F), TET3 (G), and pTET (H) are shown. 684 
Spearman’s correlation coefficient R and p-values are shown. Y-axis values are expressed as 685 
changes in FEV1/FVC% or FEV1% predicted from baseline (pre-exposure) measurements. The 686 
X-axis shows the negative log2(Iavg). The points are shape-coded by AHR status and color-687 
coded by condition. 688 
 689 
Figure 7. TET level was correlated with cytokines and chemokines in the bronchoalveolar 690 
lavage. 691 
Spearman’s correlation was computed to analyze the association between TET level and 692 
cytokine and chemokine secretions in bronchoalveolar lavages (BAL). Correlation analyses 693 
between MCP1 and TET1 (A), GM-CSF and TET2 (B), TARC and TET2 (C), Eotaxin-3 and 694 
pTET (D), and IL-5 and pTET (E) are shown. Spearman’s correlation coefficient R and p-695 
values are listed. The x-axis shows the negative log2(Iavg). (F) Using the median of TET2 level 696 
in the negative control (FA-S), 11 participants were split into two groups, including a low TET2 697 
group (n = 6) and a high TET2 group (n= 5). The heatmap shows the cytokine and chemokine 698 
secretions following exposures grouped by TET2 levels. Concentrations are shown as the 699 
square root (Sqrt) of the raw data. (G) The exposure effects of FA-A and DE-A on IL-8 secretion 700 
in the BAL were modified by TET2 levels. LME model analysis where exposure condition-by-701 
TET2 level (low TET2 vs. high TET2) interaction as the fixed effect was applied. *p<0.05. 702 
The points are shape-coded by AHR status and color-coded by condition.  703 
Table 1. Participants’ characteristics and their pDNMT and pTET for in vivo study 704 
ID AHR  Sex Age (yr.) FEV1% predicted Allergen pDNMT pTET 
1 Yes F 23 84 Grass 3A 3 
2 Yes F 24 100 HDM 3B 3 
3 Yes F 32 111 HDM 3B 2 
4 Yes F 44 114 HDM 3A 2 
5 Yes M 25 107 HDM 3B 3 
6 Yes M 28 123 Birch 3A 3 
7 Yes M 33 86 Grass 3B 3 
8 No F 28 105  HDM 3B 3 
9 No F 46 97 Grass 3A 2 
10 No M 23 105 Grass 3B 3 
11 No M 30 108 HDM 1 3 
Summary 7 Yes 6 F 30.6 ± 7.9* 103.66 ± 11.48* 6 HDM 6 DNMT3B 8 TET3 
 
4 No 5 M   4 Grass 4 DNMT3A 3 TET2 
    
 1 Birch 1 DNMT1 0 TET1 
*Mean ± SD.  705 
AHR, airway hyperresponsiveness; yr., year; FEV1% predicted, FEV1% of the patient divided by the average 706 
FEV1% in the population for any person of similar race, sex, age, and height; pDNMT, predominant DNA 707 
methyltransferase; pTET, predominant ten-eleven translocation; F, female; M, male; HDM, house dust mite; Grass, 708 
pacific grass, Birch, birch pollen. 709 
